A new trial highlights that the timing of chemoradiation and immunotherapy is crucial when treating limited-stage small cell ...

Discover the top biotech companies pioneering the next healthcare breakthroughs. Learn how innovative firms are ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

(HealthDay News) — The US Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary ...

To say that 2seventy bio’s short two years of existence have been dramatic is an understatement. CEO Chip Baird told BioSpace transparency and a committed staff have kept the biotech going through ...